Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/DYNAVAX-TECHNOLOGIES-CORP-19120561/news/Dynavax-Announces-First-Participant-Dosed-in-a-Phase-2-Clinical-Trial-Evaluating-an-Adjuvanted-Plagu-41752073/?utm_source=whatsapp&utm_medium=social&utm_campaign=share